A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. (Q38347610)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 December 2009

Language	Label	Description	Also known as
English	A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.	scientific article published on 29 December 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J F Deeken

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

T Cormier

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D K Price

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

T M Sissung

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S M Steinberg

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

K Tran

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D J Liewehr

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

W L Dahut

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

X Miao

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

W D Figg

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

29 December 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

191-199

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

https://scigraph.springernature.com/pub.10.1038/tpj.2009.57

0 references

Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Clinical pharmacokinetics of docetaxel.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Dexamethasone as a probe for docetaxel clearance.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Prediction of docetaxel response in human breast cancer by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Teratogen metabolism: spontaneous decay products of thalidomide and thalidomide analogues are not bioactivated by liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

5'-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Thalidomide metabolism and hydrolysis: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Association study of Wnt signaling pathway genes in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Transcriptional network governing the angiogenic switch in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Effects of NO-1886 (Ibrolipim), a lipoprotein lipase-promoting agent, on gene induction of cytochrome P450s, carboxylesterases, and sulfotransferases in primary cultures of human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Catalog of 77 single-nucleotide polymorphisms (SNPs) in the carbohydrate sulfotransferase 1 (CHST1) and carbohydrate sulfotransferase 3 (CHST3) genes

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Enzymatic properties, tissue-specific expression, and lysosomal location of two highly homologous rat SULT1C2 sulfotransferases

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Expression profiling of sulfotransferases in human cell lines derived from extra-hepatic tissues

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Genetic diversity and function in the human cytosolic sulfotransferases.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Bile salt transporters: molecular characterization, function, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.57

21 January 2018

Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHST1 and CHST2 sulfotransferase expression by vascular endothelial cells regulates shear-resistant leukocyte rolling via L-selectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide metabolism by the CYP2C subfamily.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity in drug disposition determines interindividual variability of docetaxel pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting P values in pharmacogenetic studies: a call for process and perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation, purification and biological activity of major docetaxel metabolites from human feces.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/20038957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/TPJ.2009.57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20038957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38347610&oldid=1577722372"